title: Update in the treatment of asthma during pregnancy.
abstract: Asthma is the most common potentially serious medical problem to complicate pregnancy. Recent reports suggest that 7 of every 100 pregnant women suffer from asthma during pregnancy. Asthmatic women have been shown to be at an increased risk of complications during pregnancy. This may be secondary to inadequately controlled asthma or perhaps the result of the effects of certain asthma medications taken during pregnancy. The choice to use a specific medication during pregnancy is based on available human and animal data. Much of the information currently available regarding the safety of various asthma medications during pregnancy comes from several large cohort studies. This article reviews the specific aspects of pharmacological therapy during pregnancy as provided in the recommendations of the joint ad hoc committee of the American College of Allergy Asthma and Immunology and the American College of Obstetricians and Gynecologists. This article presents practical strategies for the management of asthma in our pregnant patients.
authors.affiliation: Kaiser-Permanente Medical Center, San Diego, CA, USA. janamazy@yahoo.com
authors.forename: Jennifer Altamura
authors.initials: JA
authors.lastname: Namazy
authors.forename: Michael
authors.initials: M
authors.lastname: Schatz
mesh_terms: D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000453:epidemiology / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D005260:Female; D006287:Health Planning Guidelines; D006801:Humans; D007167:Immunotherapy; D008429:Maternal Welfare; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology / Q000628:therapy*; D012307:Risk Factors
chemical_list: D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents